SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Press Releases
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
October 31, 2024
 · 
2 min read
Press Releases
Hemostemix Announces the First Tranche Closing of $1.8M of Its Recently Announced Private Placement
October 31, 2024
 · 
10 min read
Press Releases
PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases
October 31, 2024
 · 
7 min read
Press Releases
Defence Therapeutics Completes 1st Tranche of Financing
October 31, 2024
 · 
4 min read
Press Releases
Medexus Schedules Second Fiscal Quarter 2025 Conference Call
October 29, 2024
 · 
3 min read
Press Releases
Maxwell Biosciences Selected to Receive a Nearly $3M Award from Medical Technology Enterprise Consortium (MTEC)
October 24, 2024
 · 
3 min read
Press Releases
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 24, 2024
 · 
3 min read
Press Releases
Telo Genomics Presents New Performance Data for Its Smoldering Myeloma Prognostic Test
October 22, 2024
 · 
5 min read
Press Releases
Awakn Announces Opening of Four Additional AWKN-001 Phase 3 Trial Sites
October 22, 2024
 · 
8 min read
Press Releases
Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis
October 22, 2024
 · 
10 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us